WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ
REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE
WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО
Assessing progress towards the global
diabetes targets in WHO European
region
Issue date: 30/05/2024
Original: English
Scope and purpose
The epidemic of diabetes continues to increase in the WHO European region; according to International
Diabetes Federation estimates, one third remains undiagnosed and up to half may not meet their treatment
targets. Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly
(WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the
burden of noncommunicable diseases through strengthening prevention and control of diabetes. The five
new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of people
with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed diabetes have
good control of blood pressure; 60% of people with diabetes of 40 years or older receive statins; and,
100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring.
The targets complement the wider noncommunicable disease agenda, supporting achievement of the 2030
Agenda for Sustainable Development, and the global and European action plans for the prevention and
control of noncommunicable diseases. Additionally, the targets specifically support the 2021 WHO
Global Diabetes Compact initiative.
In November 2023, WHO Regional Office for Europe (WHO/Europe) and International Diabetes
Federation Europe held a high-level technical summit to accelerate commitments on diabetes across the
WHO European region. During the summit, WHO/Europe presented an update of progress towards the
diabetes targets, which highlighted two key issues. Firstly, there are apparently significant data gaps for
the Region, for some targets more than others. Secondly, the current picture of progress suggests
significant gaps in outcomes, with few Member States achieving any target. Overall, there is currently not
a clear picture of progress against the diabetes targets in the WHO European region, and possibly also at
national level.
WHO/Europe have embarked on an initiative in 2024 to get a more robust assessment of performance
against the global diabetes targets across the WHO European region. A more robust picture will
ultimately help to identify gaps and support targeted action to improve outcomes for individuals with
diabetes across the region, contributing to wider noncommunicable disease targets. The WHO/Europe
initiative has firstly involved collaboration with technical experts to determine different approaches for
how the targets can be measured across the region and within countries. Subsequently, WHO/Europe will
work with several Member States to assess the targets within their country. Finally, WHO/Europe will
create a summary brief to share learning across the region on how targets can be measured at the national
level, and across the Region using varied case-studies from Member States.
As part of the initiative, WHO/Europe are holding a series of online meetings to bring together
representatives from Member States, aiming to help build a picture of how the targets can be measured
within countries. The first meeting took place on 13 May 2024 with the second scheduled for 9 July 2024,
and a further one to two meetings to follow by end 2024. The objectives of these meetings include to
familiarise Member States with the global targets, discuss different approaches for how the targets can be
Scope and purpose
page 2
measured through examples from different national contexts, and facilitate discussion on key
considerations in assessing the targets in-country.
Interested Member States may wish to follow up within their country and/or with WHO/Europe to gather
good practice on how to measure the targets. The meetings are for invited participants only.
WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION Date: 31 May 2024
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONAL OFFICE FOR EUROPE Ms Helen Sõber
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA
Adviser
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co-
Head office:
operation Department
UN City, Marmorvej 51, Ministry of Social Affairs
DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Email:
[email protected] 10122 Tallinn
Website: https://www.who.int/europe Estonia
Our reference: Your reference:
Notre référence: Votre référence:
Unser Zeichen: Ihr Zeichen:
См. наш номер: На Ваш номер:
Dear Ms Sõber,
Assessing progress towards the global diabetes targets in the WHO European region
I have the honour to inform you that the WHO Regional Office for Europe has started the above-
mentioned initiative, which includes a number of meetings.
Diabetes is one of the most common chronic conditions in Europe. At least 64 million adults
and around 300 000 children and adolescents are estimated to be living with diabetes in the WHO
European Region. Furthermore, according to International Diabetes Federation estimates, one third
remains undiagnosed and up to half may not meet their treatment targets.
Five global diabetes coverage targets were adopted at the seventy-fifth World Health Assembly
(WHA), which were developed following the seventy-fourth WHA resolution 74.4 on reducing the
burden of noncommunicable diseases through strengthening prevention and control of diabetes. The
five new targets set the standard that, by 2030: 80% of people with diabetes are diagnosed; 80% of
people with diagnosed diabetes have good control of glycaemia; 80% of people with diagnosed
diabetes have good control of blood pressure; 60% of people with diabetes of 40 years or older receive
statins; and 100% of people with type 1 diabetes have access to affordable insulin and blood glucose
self-monitoring.
The targets complement the wider noncommunicable disease agenda, supporting achievement of the
2030 Agenda for Sustainable Development, and the global and European action plans for the
prevention and control of noncommunicable diseases. Additionally, the targets specifically support the
2021 WHO Global Diabetes Compact initiative. However, there is currently not a clear picture of
progress against the diabetes targets in the WHO European Region, and possibly also at national
level.
To support Member States, WHO Regional Office for Europe is launching an initiative to get a more
robust assessment of progress against the global diabetes targets in the WHO European Region and in-
country. Assessment of the global diabetes targets across the Region can help to support targeted
action, reduce disparities, and improve outcomes for those living with diabetes. Further detail on the
initiative is available in the attached scope and purpose.
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: https://www.who.int/europe
Denmark
WHO held the first regional online technical workshop on Monday 13th May and you were invited to
nominate participants to attend. The workshop aimed to help build a picture of how the targets can be
measured within countries, specifically through sharing examples from different national contexts.
Follow-up online meetings will be arranged throughout the year to allow as many countries as
possible to participate. The second online meeting is scheduled for Tuesday 9th July 2024, and a
further one to two meetings to follow by the end of 2024. The working languages will be English and
Russian, and simultaneous interpretation will be provided.
As we did not already hear from you, we wonder if you would still be interested to provide
nominations of two participants for this initiative and the related meetings. You may wish to consider
the following as participants:
Leaders working in diabetes, such as chief endocrinologists or heads of national diabetes
programmes;
Technical experts working in non-communicable disease surveillance, eHealth or diabetes
registers.
I would be grateful if you could share the contact details (name, functional title, and email address) of
the nominated representatives by 30 June 2024. Please send the nominations by email to Anita
Strandsbjerg (
[email protected]). For questions about the workshop please contact Dr Jill
Farrington, Regional Medical Officer, Cardiovascular Disease and Diabetes (
[email protected]).
Sincerely yours,
Dr Gauden Galea
Strategic Adviser to the Regional Director
Special Initiative on NCDs and Innovation
Encls:
Provisional programme
Scope and purpose
Copy for information to:
Ms Triin Uusberg, Head, European Union Affairs and International Co-operation Department, Ministry of
Social Affairs, Suur-Ameerika 1, 10129 Tallinn, Estonia
H.E. Ms Riia Salsa-Audiffren, Ambassador Representative of the Republic of Estonia, Permanent Mission of
the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin
du Petit-Saconnex 28A, CH-1209 Genève, Switzerland
H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of
Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark
Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia
–2–
–3–
WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ
REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L'EUROPE
WELTGESUNDHEITSORGANISATION ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО
Assessing progress towards the global /4
diabetes targets in WHO European
region (second session)
Online via zoom Issue date: 30/5/2024
Tuesday 9th July 10:30-12:00 CET Original: English
Provisional programme
10:15–10:30 Technical checks for speakers
10:30–10:35 Opening
Welcome and introductions
10:35–10:50 Background and context
Briefing on policy context and purpose of initiative
This presentation will introduce the strategic context for the
global diabetes targets, alongside the WHO/Europe
initiative and rationale. This will include a summary of
current progress against the targets in WHO Europe, and
current limitations.
10:50–11:10 Measuring the global diabetes targets
WHO Europe perspective
This presentation will provide a EURO perspective on the
data sources and approaches that could be used to measure
targets across the region, alongside strengths and
limitations.
National perspectives Examples from countries
This presentation will provide country examples on how the
five diabetes targets could be measured in specific national
contexts, alongside strengths and limitations.
Questions and answers
11:10–11:50 Towards a European picture of the diabetes targets
Guided discussions
Guided discussions will provide an opportunity to discuss
reflections on how to measure the targets in different
country settings, and future involvement in the
WHO/Europe initiative.
11:50–11:55 Summary of discussions
11:55–12:00 Next steps and close of meeting
Saatja: "EURO NCD" <
[email protected]>
Saaja: "Helen Sõber"
Teema: Assessing progress towards the global diabetes targets in WHO European region (second session) - Tuesday 9th July 10:30-12:00 CET
Kuupäev: 2024-05-31 14:13
Dear Colleagues,
Please see the attached correspondence sent from the World Health
Organization, Regional Office for Europe, including a nomination letter,
scope and purpose and a provisional programme for an online meeting to be
held on July 9th, 10.30-12.00 CET.
Best regards,
Alex Monich